Beijing’s surprise move to blacklist Illumina Inc. has unleashed a frenzy among the US firm’s Chinese rivals to win market share from the gene-sequencing giant.

The DNA Sequencing Industry has rapidly transformed into one of the most crucial areas of biotechnology. What was once a time ...

The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

Velsera, a leading global healthcare technology company offering a universal software platform to connect clinical care with discovery, today reflected on a number of key achievements to date that ...

Opentrons Labworks, Inc. today introduced its Opentrons Flex® Proteomics Workstation, an automated system for common proteomics workflows, including preparing mass spectrometry (MS) samples at a cost ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

The CSP Program represents a significant milestone in Alamar's goal to accelerate scientific advancements through innovative assay solutions. Researchers can now engage with certified partners to ...

Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers ...

Set for release in 2026, the ‘first-of-its-kind’ technology aims to give researchers the ability to analyse more cells in a ...

Global Artificial Intelligence (Ai) In Precision Medicine Market was valued at USD 2.14 billion in 2023. It is expected to reach USD 19.6 billion by 2033 Lawrence John Prudour +91 91308 55334 ...

We are on the cusp of reimagining healthcare, with AI, wearables, multimodal data, AR/VR, and other innovations rapidly ...